1 |
唐晖,丁凡,姚嘉,等. 肝移植治疗多囊肝11例疗效分析[J]. 中华医学杂志,2019, 99(10): 767-770.
|
2 |
王连江,张雅敏,邓永林,等. 肝移植治疗肝脏良性肿瘤六例临床分析[J]. 中华医学杂志,2016, 96(26): 2091-2093.
|
3 |
Zhong L, Men TY, Yang GD, et al. Case report: living donor liver transplantation for giant hepatic hemangioma using a right lobe graft without the middle hepatic vein[J]. World J Surg Oncol, 2014, 12: 83.
|
4 |
陈瑞,周光文,申川,等. 肝移植治疗巨大肝脏血管瘤一例[J]. 中华外科杂志,2010, 48(10): 800.
|
5 |
Chui AK, Vass J, McCaughan GW, et al. Giant cavernous haemangioma: a rare indication for liver transplantation[J]. Aust N Z J Surg, 1996, 66(2): 122-124.
|
6 |
Gringeri E, D′Amico FE, Bassi D, et al. Liver transplantation for massive hepatomegaly due to polycystic liver disease: an extreme case[J]. Transplant Proc, 2012, 44(7): 2038-2040.
|
7 |
Yamashita Y, Maehara Y, Ikegami T, et al. Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case[J]. Surg Today, 2008, 38(5): 463-468.
|
8 |
Prodromidou A, Machairas N, Garoufalia Z, et al. Liver transplantation for giant hepatic hemangioma: a systematic review[J]. Transplant Proc, 2019, 51(2): 440-442.
|
9 |
Dios-Barbeito S, Domínguez-Bastante M, Moreno-Navas A, et al. Multicentric study of the Andalusian experience in polycystic liver disease as indication for liver transplantation[J]. Transplant Proc, 2018, 50(2): 613-616.
|
10 |
Baber JT, Hiatt JR, Busuttil RW, et al. A 20-year experience with liver transplantation for polycystic liver disease: does previous palliative surgical intervention affect outcomes?[J]. J Am Coll Surg, 2014, 219(4): 695-703.
|
11 |
Jiang WW, Zhang F, Pu LY, et al. Liver transplantation for polycystic liver with massive hepatomegaly: a case report[J]. World J Gastroenterol, 2009, 15(40): 5112-5113.
|
12 |
Liu CL, Fan ST, Lo CM, et al. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage[J]. Liver Transpl, 2004, 10(6): 728-733.
|
13 |
Fischer L, Saliba F, Kaiser GM, et al. Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: follow-up results from a randomized, multicenter study[J]. Transplantation, 2015, 99(7): 1455-1462.
|